Evidence map›Paper›PMID 32967645›Full record

ArticleBMC nephrology2020

Chronic kidney disease in Cameroon: a scoping review.

Jerry Brown Aseneh, Ben-Lawrence A Kemah, Stephane Mabouna, Mbeng Emmanuel Njang, Domin Sone Majunda Ekane, Valirie Ndip Agbor

Open access · goldAbstract readScoping Review
In one paragraph

Article in BMC nephrology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. The Aqueous Extract from the Stem Bark ofEvidence-based complementary and alternative medicine : eCAM · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Jerry Brown AsenehDepartment of Health Research, Health Education and Research Organization (HERO), Buea, Cameroon. jbaseneh@gmail.com.ORCID 0000-0002-2895-6245
Ben-Lawrence A KemahDepartment of Health Research, Health Education and Research Organization (HERO), Buea, Cameroon.
Stephane MabounaDepartment of Health Research, Health Education and Research Organization (HERO), Buea, Cameroon.
Mbeng Emmanuel NjangDepartment of Health Research, Health Education and Research Organization (HERO), Buea, Cameroon.
Domin Sone Majunda EkaneDepartment of Health Research, Health Education and Research Organization (HERO), Buea, Cameroon.
Valirie Ndip AgborDepartment of Health Research, Health Education and Research Organization (HERO), Buea, Cameroon.
KU Leuven · BERoyal Stoke University Hospital · GBUniversity of Buea · CMUniversity of Oxford · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis scoping review sought to summarize available data on the prevalence, associated factors, etiology, comorbidities, treatment, cost and mortality of chronic kidney disease (CKD) in Cameroon.

methodsWe searched PubMed, Scopus and African Journals Online from database inception to 31 March, 2020 to identify all studies published on the prevalence, associated factors, etiology, comorbidities, treatment, cost and mortality of CKD in Cameroon.

resultsThirty studies were included. The prevalence of CKD varied from 3 to 14.1 and 10.0%-14.2% in rural and urban areas, respectively. The prevalence of CKD in patients with hypertension, diabetes mellitus, and human immunodeficiency virus was 12.4-50.0, 18.5%, and 3.0-47.2%, respectively. Hypertension (22.3-59.1%), chronic glomerulonephritis (15.8-56.2%), and diabetes mellitus (15.8-56.2%) were the most common causes of CKD. The cause was unknown in 13.5-17.0% of the cases. Advanced age, hypertension, diabetes mellitus, and obesity were frequent associated factors. Hemodialysis was the main treatment modality in patients with End Stage Renal Disease (ESRD). The monthly cost of management of non-dialyzed CKD was 163 US dollars. The one-year mortality rate of ESRD was 26.8-38.6%.

conclusionChronic kidney disease affects about one in 10 adults in the general population in Cameroon. Patients with hypertension, diabetes mellitus, and human immunodeficiency virus bear the greatest burden of CKD in Cameroon. Advanced age, hypertension, diabetes mellitus, and obesity are major factors associated with CKD. Chronic kidney disease in Cameroon is associated with high morbidity and mortality and huge economic cost on the patient.

Indexed as

AdultCameroonCost of IllnessDiabetes ComplicationsDiabetes MellitusFemaleGlomerulonephritisHumansHypertensionMaleMiddle AgedObesityPopulationPrevalenceRenal DialysisRenal Insufficiency, ChronicCameroonChronic kidney diseaseEnd stage renal disease

Identifiers

PMID32967645
PMCPMC7510319
OpenAlexW3089083390

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.